Aktiesnakken — Oktober 2009
-
hehe super....
-
ja skal nu ikke klage det ser rigtigt fornuftigt ud
-
du kan kun ytre dig i genmab terminologi
-
hvornår launcher i med en UK kampagne?
-
soon soon. vi skal nok lige have investorerne ombord
-
vi har jo ikke rigtigt noget markedsføringsbudget
-
PI spredes ligesom syfillis, by word of mouth
-
nej ok.... men bliver det en UK finansering, eller samler i ind i den danske kreds igen... en UK finansering vil andet andet lige gøre
-
det mere interessant for folk fra UK at reklamere for PI
-
vi har samlet en del professionelle investorer denne gang..og så er london et wild card.....
-
men nu siger jeg nok for meget
-
ja det er forbudt at stille aka den slags spørgsmål her
-
hehe, ok så tier jeg....
-
ses gobe
-
nite
-
se hvad Biosite har kreeret:
-
og for at følge Kims' Ronco tråd: http://www.invmeduk.com/emergency-medicine/articles/biomarkers-in-acute-kidney-injury-aki-conference-report-100/
-
16 September 2009
(Neutrophil Gelatinase Associated Lipocalin) An emerging biomarker for Acute Kidney Injury. CE marked with quantitative results in - 15 minutes
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind